Memorial Sloan Kettering Cancer Center Overview
Pro stress-test →Memorial Sloan Kettering Cancer Center (MSK) was one of the first cancer centers to receive the Comprehensive Cancer Center designation from NCI in 1971, with doctors and scientists working together to fulfill the institution's commitment to patient care, research, and education. The center's high degree of specialization means that MSK's doctors treat hundreds of cancer subtypes.
Strategic Profile
Pro stress-test →MSK has been recognized as the best cancer center in the Northeast, the number two hospital for cancer care in the nation, and the number one hospital nationally for urology care by U.S. News & World Report. In May 2026, MSK appointed Shakeeb Akhter as Chief Digital Officer to oversee the overall design and execution of MSK's digital strategy. In May 2026, Turner and Consigli Construction were selected to build The Kenneth C. Griffin Pavilion, a state-of-the-art cancer care facility at MSK's main Manhattan campus.
Competitive Landscape
Pro stress-test →MSK operates in the specialized cancer care and research sector, competing with other NCI-designated Comprehensive Cancer Centers such as MD Anderson Cancer Center (Houston), Dana-Farber Cancer Institute (Boston), and Mayo Clinic (Rochester). MSK ranks second nationally for cancer care and first nationally for urology care, positioning it as a leading specialty center. The institution differentiates through its integrated research-clinical model and precision medicine capabilities.
Industry Context
Memorial Sloan Kettering Cancer Center operates in Oncology care and cancer research.
Key facts
Founded: 1980 · Headquarters: New York, US · Employees: N/A · Revenue: N/A · Market cap: N/A